Hospital-at-Home Care Bundle for Community-Acquired Pneumonia
For an ambulatory adult patient with stable vital signs, reliable caregiver support, and ability to take oral medications, a hospital-at-home care bundle should include oral combination antibiotic therapy (beta-lactam plus macrolide), daily vital sign monitoring with clear escalation criteria, oxygen saturation assessment, structured clinical response evaluation at 48-72 hours, and a defined pathway for hospital transfer if deterioration occurs.
Core Components of the Care Bundle
1. Antibiotic Therapy
Oral combination therapy is the cornerstone of treatment. The evidence strongly supports:
Beta-lactam plus macrolide combination 1, 2:
- Amoxicillin 500-1000 mg every 8 hours PLUS
- Azithromycin 500 mg on day 1, then 250 mg daily for 4 days OR
- Clarithromycin 250-500 mg every 12 hours
Alternative: Respiratory fluoroquinolone monotherapy 1, 3:
- Levofloxacin 750 mg daily OR
- Moxifloxacin 400 mg daily
The combination approach is preferred because it provides broader coverage for both typical (Streptococcus pneumoniae) and atypical pathogens (Mycoplasma, Chlamydophila) 1, 2. The 2007 IDSA/ATS guidelines provide strong level I evidence for this approach in hospitalized patients, which translates directly to hospital-at-home settings.
Duration: Minimum 5 days 1, 4, with the critical requirement that the patient must be afebrile for 48-72 hours and have no more than one sign of clinical instability before stopping therapy. Recent 2025 guidelines suggest 3-5 days may be adequate for non-severe CAP reaching clinical stability 5, 4, but err on the side of 5 days minimum for home-based care where monitoring is less intensive.
2. Daily Monitoring Protocol
Vital signs must be assessed daily with specific parameters:
- Temperature (target: afebrile for 48-72 hours before considering treatment completion)
- Respiratory rate (escalate if >30 breaths/minute) 6
- Oxygen saturation (escalate if <90% on room air)
- Blood pressure (escalate if systolic <90 mmHg or diastolic <60 mmHg) 6
- Heart rate (monitor for tachycardia >100 bpm)
These parameters directly correspond to ICU admission criteria from established guidelines 6, making them critical red flags for home monitoring.
3. Clinical Response Assessment Timeline
Structured evaluation at 48-72 hours is mandatory 6, 1:
- Assess for fever resolution
- Evaluate symptom improvement (cough, dyspnea, pleuritic pain)
- Confirm ability to maintain oral intake
- Check for progression of symptoms or new complications
If no improvement or worsening occurs at 48-72 hours, this represents treatment failure requiring immediate reassessment and likely hospital transfer 6.
Secondary assessment at 5-7 days for overall clinical improvement 6.
4. Clear Hospital Transfer Criteria
Immediate transfer to hospital if ANY of the following develop 6:
- Respiratory rate >30 breaths/minute
- Oxygen saturation <90% on room air
- Systolic BP <90 mmHg or diastolic <60 mmHg
- Altered mental status or confusion
- Inability to maintain oral intake
- Severe acidosis symptoms
- Lack of clinical improvement at 48-72 hours
These criteria are derived from ICU admission guidelines 6 and represent the threshold where home-based care becomes unsafe.
5. Supportive Care Elements
Hydration management: Ensure adequate oral fluid intake (minimum 1.5-2 liters daily unless contraindicated)
Nutrition support: Maintain caloric intake; small frequent meals if appetite is reduced
Mobilization: Early mobilization is associated with better outcomes 7. Encourage ambulation as tolerated while monitoring for fatigue or dyspnea.
Respiratory hygiene: Use of tissues, hand hygiene to prevent transmission 1
6. Caregiver Education and Commitment
The caregiver must be trained to:
- Recognize warning signs requiring immediate medical attention
- Properly administer medications on schedule
- Accurately measure and record vital signs
- Understand the importance of completing the full antibiotic course
- Know when and how to contact the medical team
This is non-negotiable for hospital-at-home care 8.
7. Communication Infrastructure
Daily check-ins with the medical team (phone or telehealth) for the first 3 days, then every 2-3 days until completion of therapy.
24/7 access to medical advice for urgent concerns.
Clear escalation pathway with predetermined contact numbers and instructions.
Critical Pitfalls to Avoid
Do not use macrolide monotherapy in areas with high pneumococcal resistance 1. The combination approach is safer for empiric therapy.
Do not delay hospital transfer if deterioration occurs. The criteria listed above are absolute indications for escalation of care.
Do not assume clinical stability means treatment completion. The patient must meet specific criteria: afebrile 48-72 hours, improving symptoms, and stable vital signs 1.
Do not skip the 6-week follow-up. A chest radiograph should be obtained at 6 weeks for patients over 50 or smokers to exclude underlying malignancy 2.
Special Considerations
For patients with penicillin allergy: Use respiratory fluoroquinolone monotherapy (levofloxacin 750 mg daily or moxifloxacin 400 mg daily) 1, 3.
For patients with recent hospitalization or antibiotic use: Consider risk factors for resistant organisms and potentially adjust empiric coverage, though this may necessitate traditional hospital admission rather than hospital-at-home 3.
Vaccination status should be assessed and pneumococcal/influenza vaccines offered if not up to date 1, 2.